Filing Details
- Accession Number:
- 0001415889-24-010059
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-04-03 17:00:11
- Reporting Period:
- 2024-04-01
- Accepted Time:
- 2024-04-03 17:00:11
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1211583 | Fennec Pharmaceuticals Inc. | FENC | Biological Products, (No Disgnostic Substances) (2836) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1468308 | Robert Andrade | C/O Fennec Pharmaceuticals, Inc. Po Box 13628, 68 Tw Alexander Drive Research Triangle Park NC 27709 | Chief Financial Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Shares | Acquisiton | 2024-04-01 | 12,500 | $0.00 | 104,271 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- Represents release of restriction from shares awarded 3-31-2023.
Billionaire Hedge Funds
